Boehringer Ingelheim· @Boehringer · X·· 2026-01-08AI 评分22
AI 导读
#NEWS：我们与@Enara_Bio合作新获得授权的Dark Antigens®强化了我们的管线，也推进了我们为选择有限的癌症患者提供创新疗法的目标。 了解更多：https://go.boehringer.com/xKq #ResearchCollaboration #CancerResearch
正文
#NEWS: Newly licensed Dark Antigens® from our collaboration with @Enara_Bio strengthen our pipeline and our goal to deliver innovative treatments for people with cancers who have limited options.
Lern more: https://go.boehringer.com/xKq
#ResearchCollaboration #CancerResearch
来源：Boehringer Ingelheim · x.com